SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a private debt exchange that effectively converted $1.4 billion of senior notes into equity, a move that the community is actively debating as either a strategic balance sheet cleanup to prepare for potential M&A or as an act of shareholder dilution. Traders are closely monitoring the 35-day volume-weighted average price window for this exchange, while retail sentiment remains deeply polarized between those betting on long-term acquisition catalysts and others expressing frustration over the stock's persistent price stagnation.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investor optimism builds around strong commercial momentum for Briumvi and the expansion into new indications like schizophrenia and myasthenia gravis. The community is actively discussing the potential for a long-term buyout and the ongoing frustration with analyst price targets that lag behind the company's growth trajectory and pipeline development.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee continues to drive intense community conversation around its massive store expansion and solid quarterly revenue growth, fueling persistent speculation about a potential future relisting. Investors are actively debating the company's long-term competitive positioning against rivals, while monitoring the ongoing share repurchase program and its impact on price stability.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is facing significant downward pressure as investors brace for the upcoming quarterly earnings release and the imminent expiration of a major insider lock-up period that threatens to flood the market with millions of shares. While the community is deeply divided between long-term believers citing the company's ambitious space infrastructure goals and bears warning of extreme valuation concerns and potential dilution, the stock remains highly volatile with intense focus on how the market will absorb the looming supply overhang.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney Co. is trending as investors weigh strong theatrical box office performance from major intellectual property releases against broader media sector volatility, while the community remains divided over its long-term streaming strategy and the potential impact of corporate restructuring rumors.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is trending as investors digest news of a potential mega-merger with AstraZeneca, a move that would reshape the pharmaceutical landscape and significantly consolidate oncology assets. The community is actively debating the strategic merits of such a deal, specifically focusing on the massive cost-cutting synergies and the necessity of shoring up a pipeline facing significant patent expirations.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending following reports that the company has secured a three-year tariff reprieve from the U.S. government by committing to significant domestic manufacturing investments and steep price discounts. Investors and market participants are actively discussing the implications of this major strategic move on the company's long-term margin profile and its competitive standing within the pharmaceutical sector.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

SPRY is facing significant volatility as investors weigh concerns over high cash burn and weak commercial adoption against the company's status as the only needle-free epinephrine option. The community remains divided, with some betting on a short squeeze driven by high short interest and upcoming CVS Caremark formulary decisions, while others remain skeptical of management's ability to achieve profitability.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is generating strong investor interest and heavy social media activity as the market debates its valuation ahead of upcoming earnings, with community members actively discussing its high margins and AI-driven growth potential. While some investors remain cautious about volatility and sector-wide software trends, many are viewing recent pullbacks as attractive opportunities for long-term accumulation, closely monitoring key technical support levels and management's execution on new monetization platforms.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is in focus as it faces an FDA advisory committee review to determine the fate of its melanoma treatment, with the community deeply divided between those betting on an approval to address unmet medical needs and those expecting a third rejection due to concerns over clinical data integrity. Investors are closely monitoring the committee's vote for signs of a potential short squeeze or a final complete response letter, as the stock experiences significant volatility ahead of the upcoming PDUFA decision.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
